Evaluation of Androgen Levels in Patients with Acute Coronary Syndrome
Evaluation of Androgen Levels in Patients with Acute Coronary Syndrome
Objectives: To determine plasma levels of free Testosterone (fT) and dehydroepiandrosterone sulphate (DHEA-S) in male patients with acute coronary syndrome. Methods: We checked the serum fT and DHEA-S levels of 30 healty male subjects and 64 male patients with acute coronary syndrome whose coronary artery diseases were confirmed by coronary angiography. Results: We observed no difference between two groups on the level of fT while DHEA-S level was significantly lower (p = 0.01). No correlation had existed between lipid parameters and levels of fT and DHEA-S. Conclusion: More comprehensive studies are needed about whether lower levels of DHEAS in patients are contributed to acute coronary syndrome or are the effect of disease.
___
- Yadav P, Joseph D, Joshi P, Sakhi P, Jha RK, Gupta J. Clinical profile and risk factors in acute coronary syndrome. NJCM. 2010;1(2):150-2.
- Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall EE. Risk factors for coronary heart disease: implications of gender. Cardiovasc Res. 2002;53(3):538-49.
- Schildkraut JM, Myers RH, Cupples LA, Kiely DK, Kannel WB. Coronary risk associated with age and sex of parental heart disease in the Framingh Study. Am J Cardiol. 1989;15:555-9.
- Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24(3):313-40.
- Akishita M, Hashimoto M, Ohike Y, Ogawa S, Iijima K, Eto M, et al. Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res. 2007;30:1029-34.
- Fukui M, Ose H, Kitagawa Y, Yamazaki M, Hasegawa G, Yoshikawa T, et al. Relationship between low serum endogenous androgen concentrations and arterial stiffness in men with type 2 diabetes mellitus. Metabol. 2007;56:1167-73.
- Pugh PJ, Channer KS, Parry H, Downes T, Jone TH. Bio-available testosterone levels fall acutely following myocardial infarction in men: association with fibrinolytic factors. Endocr Res. 2002;28:161-73.
- Helaly M, Daoud E, and El-Mashad N. Does the serum testosterone level has a relation to coronary artery disease in elderly men? Curr Gerontol Geriatr Res. 2011;2011:1-6.
- Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men. Aprospective population-based study. Circulation. 1998;78:539-45.
- Cauley JA, Gutai JP, Kuller LH, Dai S. Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. Am J Cardiol. 1987;60:771-7.
- Kabakci G, Yildirir A, Can I, Unsal I, Erbas B. Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography. Cardiology. 1992;92:221-5.
- Slowinska-Srzednicka J, Zgliczyński S, Ciświcka-Sznajderman M, Srzednicki M, Soszyński P, Biernacka M, et al. Decreased plasma dehydroepiandrosterone sulfate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis. 1989;79:197-203.
- Ponholzer A, Madersbacher S, Rauchenwald M, Jungwirth S, Fischer P, Tragl KH. Vascular risk factors and their association to serum androgen levels in a population- based cohort of 75-year-old men over 5 years: results of the VITA study. World J Urol. 2002;28:209-14.
- Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? JAMA. 1986;256:2823-8.
- Tchernof A, Labrie F. Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. Eur J Endocrinol. 2004;151:1-14.
- Kaushik M, Sontineni SP, Hunter C. Cardiovascular disease and androgens: A review. Int J Cardiol. 2010;142:8-14.
- Vermeulen A. Androgen replecament theraphy in the aging male. A critical evaluation. J Clin Endocrinol Metab. 2001;86:2380-90.
- Nestler JE, Clore JN, Blackard WG. Dehydroepiandrosterone: the ‘missing link’ between hyperinsulinemia and atherosclerosis? FASEB J. 1992;6:3073-5.
- Barud W, Palusiński R, Bełtowski J, Wójcicka G. Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males. Atherosclerosis. 2002;164:283-8.
- Haffner SM, Mykkanen L, Valdez RA, Katz MS. Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. J Clin Endocrinol Metabol. 1993;77:1610- 5.
- Haffner SM, Newcomb PA, Marcus PM, Klein BE, Klein R. Relation of sex hormones and dehydroepiandrosterone sulfate (DHEA-SO4) to cardiovascular risk factors in postmenopausal women. Am J Epidemiol. 1995;142:925-34.
- Tchernof A. Despre´s JP. Sex steroid hormones, sex hormone binding globulin, and obesity in men and women. Hormone and Metabol Res. 2000;32:526-36.
- Pitt B, Loscalzo J, Ycas J, Raichlen JS. Lipid levels after acute coronary syndromes. J Am Coll Cardiol. 2008;51:1440-5.
- Byington RP, Worthy J, Craven T, Furberg CD. Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience. Am J Cardiol. 1990;65:1287-91.
- Leidig Jr GA, Pasternak RC, Horowitz G, Ginsburg GS. Effects of heparin and cardiac catheterization on serum lipoprotein and triglyceride levels. Am J Cardiol. 1994;74:47-52.